The California biotech has drawn partnerships with Eli Lilly and J&J on the promise of its approach to rebalancing the immune ...
ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitis ZORYVE, a next-generation topical phosphodiesterase-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback